A Patient With Chronic Myeloid Leukemia Referred for Cardiovascular Assessment Before Treatment With TKI
A 40-year-old man without previous history of cardiovascular disease has been referred to the cardio-oncology clinic for cardiovascular assessment before starting nilotinib. He has been recently diagnosed with chronic myeloid leukemia. He has a history of diet-controlled diabetes and has dyslipidemia, for which he is on atorvastatin. His vitals are within normal limits, and his physical exam is unremarkable. His total cholesterol is 3.26 mmol/L (triglycerides = 0.92 mmol/L, high-density lipoprotein = 1.06 mmol/L, and low-density lipoprotein = 1.78 mmol/L).
Which of the following statements is correct?